PRoducing Outcome Measures for OTP Quality Improvement
Key facts
- Who runs it
- RTI International
- Where
- Research Triangle Park, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 4,500 people, planned
- Started
- 3 Oct 2025
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Quality Measures (Audit and Feedback)
- Quality Improvement (QI) Toolkit
- External QI Facilitation
- Record updated
- 27 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show the criterionShow less
Other criteria
- Only BayMark OTPs are eligible for participation
Where in United States
- RTI InternationalResearch Triangle Park, United StatesContact: Tami L Mark, PhDTaking people
About the trial
What the trial wants to find out
This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care.
Read full original descriptionShow less
Forty-five BayMark OTPs in multiple states will be randomly assigned to one of three groups: (1) quality measures + QI toolkit; (2) quality measures + QI toolkit + external QI facilitation; or (3) usual care.
The primary outcome is 90-day retention in treatment, measured from OTP electronic health records and Medicaid claims. Secondary outcomes include emergency department visits, hospitalizations, overdoses, and mortality. Findings will identify practical, scalable strategies to improve patient retention in OTPs.
The 3 groups in the trial
- Arm 1 - Title: Quality Measures + QI ToolkitTreatment being tested
OTPs in this arm receive clinic-level quality measures (claims-based, case-mix-adjusted retention/outcome measures with benchmarks and peer comparisons) plus a self-guided QI toolkit (evidence summaries, change packages, templates, and examples) to support retention-focused practice changes. No external facilitation is provided
Treatment: Quality Measures (Audit and Feedback) and Quality Improvement (QI) Toolkit
- Arm 2 - Title: Quality Measures + QI Toolkit + External QI FacilitationTreatment being tested
OTPs receive the quality measures and QI toolkit as in Arm 1 plus structured external QI facilitation based on the NIATx model. Facilitators coach an OTP change team, review data, and guide PDSA cycles to implement retention-focused improvements
Treatment: Quality Measures (Audit and Feedback), Quality Improvement (QI) Toolkit, and External QI Facilitation
- Arm 3 - Title: No Intervention: Usual CareNo study treatment, for comparison
OTPs continue usual practice without access to the quality measures or QI toolkit and with no external facilitation during the study. Outcomes are assessed from EHR and Medicaid claims.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On: Project 2 - Producing Outcome Measures for OTP Quality Improvement
- Record updated
- 27 August 2026